Early Intracoronary N-Acetylcysteine During Primary PCI in STEMI: A Pilot Randomized Trial of Reperfusion Injury Biomarkers and Functional Recovery

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT06850831

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA (from the registry)
Registry
  • NCT NCT06850831
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06850831. Randomized; double masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2026-03-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Intracoronary N-Acetylcysteine During Primary PCI in STEMI: A Pilot Randomized Trial of Reperfusion Injury Biomarkers and Functional Recovery
Condition
STEMI - ST Elevation Myocardial Infarction (MI)
Intervention (Drug)
Antipac
Lead sponsor
dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA (class: other)

Record details

Record id
cardio:ct-nct06850831
Content hash
b56857bde8faf619128c9c0e2442b2609b1c4c8c85893549b393f30bcf4c4ff5